US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Akoya BioSciences Inc (AKYA)
Akoya BioSciences Inc (AKYA) ニュース

AKYA

Akoya BioSciences (AKYA)

Akoya BioSciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AKYA

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/04	10 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/09/04	10 : 40	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/08/28	23 : 45	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:AKYA	Akoya BioSciences Inc
2024/08/06	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKYA	Akoya BioSciences Inc
2024/08/06	05 : 00	GlobeNewswire Inc.	Akoya Biosciences Reports Second Quarter 2024 Financial Results	NASDAQ:AKYA	Akoya BioSciences Inc
2024/07/16	05 : 00	GlobeNewswire Inc.	Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences	NASDAQ:AKYA	Akoya BioSciences Inc
2024/06/13	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/06/12	05 : 36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/06/08	10 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/06/08	10 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/06/07	05 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/06/05	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKYA	Akoya BioSciences Inc
2024/05/14	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKYA	Akoya BioSciences Inc
2024/05/14	05 : 00	GlobeNewswire Inc.	Akoya Biosciences Reports First Quarter 2024 Financial Results	NASDAQ:AKYA	Akoya BioSciences Inc
2024/05/09	21 : 00	GlobeNewswire Inc.	Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients	NASDAQ:AKYA	Akoya BioSciences Inc
2024/05/06	21 : 00	GlobeNewswire Inc.	Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts	NASDAQ:AKYA	Akoya BioSciences Inc
2024/05/02	21 : 00	GlobeNewswire Inc.	Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows	NASDAQ:AKYA	Akoya BioSciences Inc
2024/04/23	05 : 05	GlobeNewswire Inc.	Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024	NASDAQ:AKYA	Akoya BioSciences Inc
2024/04/05	21 : 00	GlobeNewswire Inc.	Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/05	07 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/05	06 : 05	GlobeNewswire Inc.	Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/04	20 : 01	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/03/02	11 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AKYA	Akoya BioSciences Inc
2024/02/12	23 : 11	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:AKYA	Akoya BioSciences Inc

Showing the most relevant articles for your search:NASDAQ:AKYA

1 2 3 4 5 6 7 8 次へ >>

Health Care Select Sector

US Dollar vs Yen

Verizon Communications

American Express

Energy Select Sector SPDR

Financial Select Sector

Bank of America

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約